Department of Hospital Medicine, Kaiser Permanente Northwest, Portland, OR.
Department of Family Medicine, Kaiser Permanente San Diego Medical Center, CA.
Perm J. 2020;24. doi: 10.7812/TPP/18.036. Epub 2019 Dec 30.
Current guidelines recommend a nonfluoroquinolone agent as first-line treatment of acute uncomplicated cystitis (AUC) because of concerns of antimicrobial resistance and adverse effects.
To test whether a multifaceted intervention involving education and feedback reduced primary care practitioners' ciprofloxacin prescriptions for AUC therapy.
Primary care practitioners at 3 medical offices participated: 65 in the intervention group and 51 in the control group. Intervention group participants received an educational lecture and emailed summary of antimicrobial guidelines, their AUC prescriptions were audited, and feedback was provided on inappropriate antibiotic choices. Prescriptions at AUC encounters were tracked during baseline, intervention, and postintervention periods.
Proportion of AUC encounters at which ciprofloxacin was prescribed vs recommended first-line antibiotics.
Intervention group participants had 5262 eligible AUC encounters, and control group participants had 5473. At baseline, ciprofloxacin was prescribed at 29.7% and 33.7% of eligible AUC encounters in the intervention and control groups, respectively (p = 0.003). After intervention, ciprofloxacin was prescribed at 10.8% of eligible AUC encounters in the intervention group and 34.3% in the control (p < 0.001). Adjusted odds ratios of ciprofloxacin prescription for AUC therapy were significantly lower in the intervention group during postintervention and intervention periods vs baseline (0.29, 95% confidence interval = 0.20-0.44, p < 0.001 and 0.80, 95% confidence interval = 0.66-0.97, p = 0.03). Adjusted odds ratios did not change over time in the controls.
Educating primary care practitioners and conducting audit and feedback reduced their prescriptions of ciprofloxacin for AUC therapy.
由于对抗生素耐药性和不良反应的担忧,目前的指南建议将非氟喹诺酮类药物作为急性单纯性膀胱炎(AUC)的一线治疗药物。
测试包括教育和反馈在内的多方面干预措施是否可以减少初级保健医生治疗 AUC 时开具环丙沙星处方的情况。
3 家医疗办公室的初级保健医生参与了这项研究:干预组 65 名,对照组 51 名。干预组参与者接受了一次教育讲座和电子邮件形式的抗生素指南摘要,他们的 AUC 处方被审核,并对不适当的抗生素选择提供反馈。在基线、干预和干预后期间,跟踪 AUC 就诊时的处方情况。
开具 AUC 处方时选择环丙沙星与推荐一线抗生素的比例。
干预组参与者有 5262 例符合条件的 AUC 就诊,对照组参与者有 5473 例。在基线时,干预组和对照组分别有 29.7%和 33.7%的合格 AUC 就诊处方为环丙沙星(p=0.003)。干预后,干预组有 10.8%的合格 AUC 就诊处方开了环丙沙星,而对照组则有 34.3%(p<0.001)。与基线相比,干预组在干预后和干预期间,AUC 治疗处方中开具环丙沙星的调整后优势比显著降低(0.29,95%置信区间=0.20-0.44,p<0.001 和 0.80,95%置信区间=0.66-0.97,p=0.03)。对照组的调整后优势比在整个研究期间没有变化。
教育初级保健医生并进行审核和反馈减少了他们开具环丙沙星治疗 AUC 的处方。